Hyundai records losses in robotics and autonomy investments

According to company filings reported by UPI, Hyundai Motor Group's three core future-business affiliates - robotics, autonomous driving and advanced air mobility - recorded accumulated equity-method losses of 2.21 trillion won (about $1.5 billion) over the past five years. The filings show the combined book value of those affiliates at 4.41 trillion won (about $2.9 billion) as of the first quarter, with 2.72 trillion won in HMG Global, 1.49 trillion won in Motional and 197.5 billion won in Supernal. The filings break the accumulated losses down as 487 billion won from HMG Global, 888.5 billion won from Motional and 835.4 billion won from Supernal, per UPI.

UPI reports HMG Global, established in the United States in 2022, serves as an investment holding company for the group's robotics and AI businesses. UPI states Hyundai Motor holds 49.5%, Kia Corp. 30.5%, and Hyundai Mobis Co. 20.0% of HMG Global. The article also reports HMG Global holds 56.25% of Boston Dynamics. UPI cites a Boston Dynamics roadmap unveiled after CES 2026 that targets an annual Atlas production system of 30,000 units by 2028, and reports market valuation estimates for Boston Dynamics between 30 trillion and 60 trillion won (about $19.9 billion to $39.8 billion), with some securities firms and banks estimating valuations above 100 trillion (about $66.3 billion).

Companies building hardware-heavy robotics and autonomous-vehicle lines typically accept large upfront capital expenditure and operating losses while they develop production processes, software stacks, and safety validation regimes. For practitioners, that pattern means engineering teams often face long development horizons, significant systems-integration work, and pressure to demonstrate scalable, repeatable production and validation rather than incremental algorithmic research alone.

Observed patterns in comparable automotive and robotics investments show milestones that materially alter valuation and operational risk: demonstrable production throughput, commercially deployed fleets, regulatory approvals, and software reliability metrics from real-world operations. Market valuation ranges cited by UPI for Boston Dynamics reflect investor sensitivity to those milestones; the wide spread signals uncertainty about commercialization timelines and addressable markets.

Observers following the sector will watch for reported production ramp metrics for Atlas, details on the planned deployments at Hyundai Motor Group Metaplant America in Georgia and subsequent plant rollouts, commercial milestones or revenue recognition from Motional and Supernal, and any updated disclosures to the Financial Supervisory Service that change book values or loss recognition. These indicators will clarify whether current investment levels are translating into scalable deployments or continuing to be primarily exploratory R&D.